Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research

Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

… Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research …

Making Mesothelioma Patient Research Happen: The United Kingdom Experience

… Making Mesothelioma Patient Research Happen: The United Kingdom Experience …

Research’s Race to Stop a Pandemic

… Research’s Race to Stop a Pandemic … Leah Lawrence …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… of ADCs with TKIs. 18  Learn more about the latest in ADC research here. Physicians and patients alike question which … failure of EGFR-TKI therapy. Translational Lung Cancer Research. 2021;10(9):3782-92. 7.  Itchins M, Ainsworth H, … COMPARING OUTCOMES OF VARIOUS TREATMENT REGIMENS IN THE SEARCH FOR THE BEST-PERFORMING APPROACH. … Challenges of …

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

… in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards … in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

Should Biomarkers Be Used in the Clinical Management of ES-SCLC?

… not there yet. We can’t force it.” He said having recent research that has demonstrated the heterogeneity of SCLC is a huge first step. As is other recent research showing that liquid biopsy can be used to identify …

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

… combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced …

Gender Disparity in Lung Cancer

… for gender-sensitive approaches in healthcare policy, research, and clinical practice. … Gender Disparity in Lung …

ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC

… Spigel, MD, Chief Scientific Officer at the Sarah Cannon Research Institute in Nashville, Tennessee, as he began his …